Demet Doğan

Dr. Demet Doğan

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

5 June 2023 in Medical Science and Discovery
Verified
Journal Article
Open access
PDF file
DDDemet Doğan
Demet Doğan
NUNazlı Uçar
Nazlı Uçar
Objective: Haglund's Deformity is a variation of the posterosuperior region enlargement of the Os Calcaneus (OC) in the form of exostosis. It is associated with Haglund's Disease (HD), which encompasses Achilles tendinitis, retrocalcaneal bursitis, supra calcaneal bursitis, and inflammation of the Kager fat pad. Diagnosis is based on clinical findings and radiological methods, such as lateral ankle radiographs, Computed Tomography (CT), and Magnetic Resonance Imaging (MRI). This study aims to present three cases of ankle pain diagnosed with HD using radiological imaging. The mean age of our cases was 44.6 years, with two females and one male. Patients commonly present with complaints of pain and swelling behind the heel. Results: Physical examination revealed pain and tenderness upon palpation over the left OC and Achilles tendon insertion. Radiological examination showed osseous protrusion in the posterosuperior part of the OC, indicating Haglund's Deformity. Edema was observed at the bony prominence of the posterosuperior OC, Kager fat pad, and heel area. The treatment plan for all three patients included leg rest splint, anti-inflammatory medication, and physical therapy. Conclusion: In cases of heel pain where traumatic events such as acute fractures are ruled out, MRI should be performed, and Haglund's Syndrome should be investigated if osseous protrusion in the posterosuperior calcaneus is observed on radiographs, along with other findings suggestive of HS.

1 December 2024 in Journal of Surgery and Medicine
Verified
Journal Article
Open access
KGKağan Gökçe
Kağan Gökçe
DDDemet Doğan
Demet Doğan
MYMerve Yazıcı
Merve Yazıcı
AKAyşe Nimet Karadayı
Ayşe Nimet Karadayı
AMAhmet Midi
Ahmet Midi
Malignant fibrous histiocytoma (MFH), while rare, is the most prevalent soft tissue sarcoma (STS) found in extremities. Its prognosis hinges on factors such as tumor size, invasion depth, and differentiation degree. For MFH and all STSs, wide surgical resection is the gold standard treatment method. In this study, a 48-year-old woman, initially diagnosed with lipoma and with a mass excised from her right forearm, later exhibited recurring MFH masses in the same location. Superficial tissue ultrasonography identified malignant soft tissue tumors in the lesion area. Positron emission tomography was used to stage the tumor preoperatively, revealing fluorodeoxyglucose uptake in the repeating lesions. Right forearm magnetic resonance imaging confirmed the malignant lesions. Post imaging, the patient underwent wide surgical excision, eliminating the fascia. Regular follow-up revealed no recurrence or metastasis at 6 months and 1 year. Excisions frequently occur without radiological imaging, based only on a preliminary lipoma or sebaceous cyst diagnosis. However, excisions should follow radiological imaging, particularly when soft tissue tumors beneath the skin appear benign.

19 April 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
DDDemet Doğan
Demet Doğan
CÖCOŞKU ÖKSÜZ
COŞKU ÖKSÜZ
ÖÇÖZGÜR ÇAKIR
ÖZGÜR ÇAKIR
OUOğuzhan Urhan
Oğuzhan Urhan
Background/Objectives: Carcinoembryonic antigen (CEA) is widely used in colon cancer management; however, its diagnostic and prognostic accuracy is limited by biological variability, as well as false-positive or false-negative results. Radiomics provides quantitative descriptors of tumor heterogeneity and offers objective assessment of tumor characteristics. This study aimed to evaluate the potential of computed tomography (CT)-based radiomic features to distinguish between CEA-positive and CEA-negative colon cancer patients. Methods: In this retrospective study, 150 patients with histopathologically confirmed colon cancer were screened, and 109 were eligible after image-quality assessment (53 CEA-positive, 56 CEA-negative). A total of 107 radiomic features were extracted from preoperative contrast-enhanced CT images. After z-score normalization, feature robustness was assessed using intra- and inter-observer agreement. Correlation-based feature selection (|ρ| ≥ 0.7) was applied. Five machine-learning classifiers—Support Vector Machine (SVM), Decision Tree, Ensemble, k-Nearest Neighbor (k-NN), and Neural Network (NN)—were trained using stratified 5-fold cross-validation. Performance was evaluated using accuracy, recall, specificity, F1-score, and ROC-AUC. Results: The best performance was obtained with 41 selected features. The k-NN classifier achieved the highest accuracy (77.4 ± 2%) and ROC-AUC (0.8523 ± 0.013), while SVM and NN achieved the highest recall (83.0 ± 0.3). These models showed balanced and robust performance in distinguishing CEA-positive from CEA-negative patients. Conclusions: CT-based radiomic analysis combined with machine learning—particularly k-NN, SVM, and neural network classifiers—showed promising performance in differentiating colon cancer patients according to serum CEA status. Radiomic features may provide imaging-based information associated with serum biomarkers such as CEA, potentially enhancing tumor characterization and supporting more personalized decision-making.

27 April 2026 in Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
Verified
Journal Article
Closed access
ÖÇÖZGÜR ÇAKIR
ÖZGÜR ÇAKIR
CÖCOŞKU ÖKSÜZ
COŞKU ÖKSÜZ
SŞSimge Şahin
Simge Şahin
AKAlican Kuran
Alican Kuran
DDDemet Doğan
Demet Doğan
OUOğuzhan Urhan
Oğuzhan Urhan

11 June 2026 in Biomedicines
Verified
Journal Article
Open access
PDF file
DDDemet Doğan
Demet Doğan
CÖCOŞKU ÖKSÜZ
COŞKU ÖKSÜZ
ÖÇÖZGÜR ÇAKIR
ÖZGÜR ÇAKIR
ZGZuhal Güllü
Zuhal Güllü
OUOğuzhan Urhan
Oğuzhan Urhan
Background/Objectives: Differentiating mediastinal lymphadenopathy associated with lung cancer from sarcoidosis remains a clinical challenge because of overlapping imaging findings. This study evaluated whether CT-derived radiomic features, alone and in combination with clinical variables, could support the non-invasive differentiation of these two entities. Methods: In this retrospective single-center study, 204 histopathologically confirmed mediastinal lymph nodes were analyzed. A total of 107 radiomic features were extracted from manually segmented contrast-enhanced thoracic CT images. Multiple feature selection methods, dimensionality reduction techniques, and machine learning classifiers were evaluated using patient-level five-fold cross-validation. Additional clinical-only, combined clinical–radiomic, one-node-per-patient sensitivity, and exploratory interobserver feature stability analyses were performed. Results: Among radiomics-only models, LASSO achieved the highest ROC–AUC of 0.9108, whereas ElasticNet achieved the highest accuracy of 81.20%. The clinical-only ensemble model using age, sex, and smoking status showed strong performance, with an accuracy of 94.92% and an ROC–AUC of 0.9733. Selected combined clinical–radiomic models showed numerically higher performance; the combined correlation-filtered ensemble model achieved the highest accuracy of 97.78% and an ROC–AUC of 1.0000. Clinical integration also yielded more compact feature subsets in some methods, as combined LASSO selected 9.6 variables while improving ROC–AUC from 0.9108 to 0.9667 compared with radiomics-only LASSO. In the one-node-per-patient sensitivity analysis, clinical-only and combined models retained high performance, whereas radiomics-only LASSO showed reduced performance. Exploratory interobserver analysis showed moderate reproducibility for only a subset of radiomic features. Conclusions: CT-derived radiomic features may provide complementary information for differentiating mediastinal lymphadenopathy associated with lung cancer from that associated with sarcoidosis. However, clinical variables were highly informative, and the incremental value of radiomics should be interpreted cautiously. Further multicenter studies with external validation, standardized segmentation protocols, and clinically balanced cohorts are required before routine clinical implementation can be recommended.